APOE and Alzheimer disease: Our results establish robust methods for modeling α-synuclein pathological phenotypes in human brain tissue and highlight a causal role of astrocytes and lipids in APOE4-mediated α-Syn pathologies, opening new therapeutic opportunities AD, LBD, and other neurodegenerative diseases.